GSC
LAB icon

Ground Swell Capital’s Standard BioTools LAB Stock Holding History

Ground Swell Capital’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.6K Buy
+11,664
New +$11K 0.01% 120
2024
Q3 		– Sell
-12,049
Closed -$21.3K – 220
2024
Q2 		$21.3K Buy
+12,049
New +$29.5K 0.02% 128
2014
Q3 		– Sell
-1,019
Closed -$30K – 2594
2014
Q2 		$30K Buy
+1,019
New +$32.7K 0.06% 280

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Ground Swell Capital's LAB Position: Q2 2026 in Review

Ground Swell Capital opened a new position in Standard BioTools (LAB) in Q2 2026: 11,664 shares worth $9.6K. The stake represents 0.01% of the portfolio and ranks #120 among its holdings. This is a return to the name: Ground Swell Capital previously reported a position in LAB as recently as Q2 2024.

Ground Swell Capital first reported a position in LAB in Q2 2014 and has held it in 3 quarters since. The position peaked at $30K in Q2 2014. 144 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Ground Swell Capital held 11,664 shares of Standard BioTools worth $9.6K as of Q2 2026.
  • Standard BioTools was a new Ground Swell Capital position in Q2 2026.
  • Standard BioTools made up 0.01% of Ground Swell Capital's portfolio in Q2 2026, its #120 holding.
  • Ground Swell Capital first reported a position in Standard BioTools in Q2 2014 and has held it in 3 quarters since.
  • Ground Swell Capital's Standard BioTools position peaked at $30K in Q2 2014.
  • 144 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Ground Swell Capital's 13F filing for Q2 2026, filed 5 Aug 2026.